Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Study finds high prevalence of drug interactions in adults taking Paxlovid
Sorry if posted before
https://www.cidrap.umn.edu/covid-19/study-finds-high-prevalence-drug-interactions-adults-taking-paxlovid
Paxlovid to see price increase
https://arstechnica.com/health/2023/10/covid-antiviral-paxlovid-to-see-price-increase-following-400-vaccine-hike/
lol, I was expecting a link to the FDA
Reuters article on weight loss drug side effects
https://www.reuters.com/business/healthcare-pharmaceuticals/biotech-firms-target-weight-loss-drugs-without-wegovys-side-effects-2023-07-07/
That Florida “analysis” on COVID vaccines is—you guessed it—total garbage
https://arstechnica.com/science/2022/10/that-florida-analysis-on-covid-vaccines-is-you-guessed-it-total-garbage/
In November 2021, Malhotra appeared on GB News to discuss an abstract for an academic poster published by Steven Gundry and which the American Heart Association had warned may contain "potential errors". Malhotra claimed that the abstract supported "a significantly increased risk from 11% at five years, the risk of heart attack, to 25%." after taking mRNA vaccines against COVID-19. Full Fact warned that "Serious concerns have been raised as to the quality of the research".[63]
Update on Pfizer's aquisition of Trillium and other cd47 competitors
https://www.fiercebiotech.com/biotech/pfizer-undeterred-cd47-plans-competitors-face-pitfalls
Demand for Pfizer's COVID pills lags around the world
https://www.reuters.com/business/healthcare-pharmaceuticals/demand-pfizers-covid-pills-lags-around-world-2022-04-19/
Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes
article on Covid antivirals
https://finance.yahoo.com/m/2bec621f-b6d0-3f37-b643-23d3ef641416/can-anyone-challenge-pfizer%27s.html?src=A00220&yptr=yahoo
Cassava : Expression of Concern from the Journal of Neuroscience.
x
Alexander Trevelyan
@ClicksAndHisses
· Dec 17
$SAVA And there we have it. After much consternation, an Expression of Concern from the Journal of Neuroscience.
https://jneurosci.org/content/early/2021/12/16/JNEUROSCI.2306-21.2021…
@jesse_brodkin @Adrian_H @MicrobiomDigest
https://www.jneurosci.org/content/early/2021/12/16/JNEUROSCI.2306-21.2021
Intercept withdraws ema application
https://finance.yahoo.com/news/intercept-announces-withdrawal-ema-marketing-120000672.html
ALXO. -25% on update of CD47 checkpoint drug
https://finance.yahoo.com/news/alx-oncology-announces-updated-data-120000228.html
thank you both for the insight.
Looking at the citation
“9. Data for PF-07321332 generated by Enanta“
I believe this is the exact opposite of your reply. Perhaps Enanta took published data from PFE and were able to infer values for their categories of scoring in the table but it reads to me as if Enabta generated the data
todays positive news about PFE's drug was worth $25 billion in additional market cap today
Anyone know how Enanta was able to get a sample of the drug?
9. Data for PF-07321332 generated by Enanta
an opinion on the relevance of the SAVA bill of health
Adam Feuerstein Syringe
@adamfeuerstein
·
20h
$SAVA Nothing disclosed today improves fundamentals or increases likelihood of simufilam’s success. It only makes the stock price more volatile, so trade on.
Will simufilam work? No, almost certainly not. When will the truth be revealed? It’s anyone’s guess. That’s biotech.
US surgeons successfully test pig kidney transplant in human patient
https://www.cnn.com/2021/10/20/health/human-pig-kidney-transplant-scli-intl-scn/index.html
I owned a lot of IMCL at the time and as the news started coming out I sold, one of the boldest and best investments I’ve ever seen was by Randychub buying at near a low, he must of made millions and I was so happy for him( if it’s a him ).
Now that the vaccine mandate has been applied to my government research facility the number of those who vaccinated has greatly increased. Previously the reported vaccination rate was 58% and this increased to 82% of the total civil servants at the lab. This equates to a 92% vaccination rate of the respondents to the required survey. Obviously some are not willing to report their vaccination status
Odds of AGN of making the FOoI request? Smart move and there are many people with hands in both pots imo
no one else got sued so kind of a compliment
with the huge amounts of money involved its not a surprise.. interesting to see if a judge issues a injunction
i'm seeing nothing but the headlines "Botox war: East Bay challenger sued by maker of blockbuster cosmetic toxin"
The corporate slide set has been updated
https://s22.q4cdn.com/306858242/files/doc_presentations/2021/10/Enanta-Corporate-Presentation-10.4.21.pdf
the reporting data is only provided for the entire lab due to privacy laws.
The data is presented each week when the center director updates the government response. This week it was about the requirement to get vaccinated, the consequences of not getting vaccinated (disciplinary action.. as yet undefined) and the dates the second shot must be received by if its a 2 shot vaccine. This data is on the local facility website but not available to outside those who don't have PIV access.
Sorry for not providing a link so dismiss it if you like. I was somewhat shocked it was that low.
I work at a government research facility and our vaccination rate is 58%.
ENANTA mention with Luly brief comments
https://finance.yahoo.com/news/focus-covid-19-pill-developers-110000105.html
BBW on that one, that company releases some of the biggest BS press releases I've ever seen. There was a short narrative written (SeekingAlpha I believe) a few years back about the CEO etc.
With the world wide press coverage of today’s meeting I’m sure many in the press and public were wondering about the new longer lasting Botox
Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery
https://finance.yahoo.com/news/revance-announces-publication-results-static-120000538.html
I still would liked to of seen the solid turmor early data before they sold the company. Congrats on the Trillium profit.
Article on the cost of Aduhelms approval.
https://finance.yahoo.com/news/column-fdas-hasty-approval-alzheimers-144244083.html
FDA advisor resigns after Alzheimer's drug approval https://www.cnn.com/2021/06/10/health/fda-adviser-resigns-alzheimers/index.html
and all of the other doses not so far reported are lower than from todays data